標題: Titlebook: Contemporary Bone Marrow Transplantation; Mammen Chandy,Vivek S. Radhakrishnan,Reghu K. Suku Reference work 2021 Springer Nature Switzerla [打印本頁] 作者: Wilder 時間: 2025-3-21 18:09
書目名稱Contemporary Bone Marrow Transplantation影響因子(影響力)
書目名稱Contemporary Bone Marrow Transplantation影響因子(影響力)學(xué)科排名
書目名稱Contemporary Bone Marrow Transplantation網(wǎng)絡(luò)公開度
書目名稱Contemporary Bone Marrow Transplantation網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Contemporary Bone Marrow Transplantation被引頻次
書目名稱Contemporary Bone Marrow Transplantation被引頻次學(xué)科排名
書目名稱Contemporary Bone Marrow Transplantation年度引用
書目名稱Contemporary Bone Marrow Transplantation年度引用學(xué)科排名
書目名稱Contemporary Bone Marrow Transplantation讀者反饋
書目名稱Contemporary Bone Marrow Transplantation讀者反饋學(xué)科排名
作者: 祝賀 時間: 2025-3-21 20:30 作者: OATH 時間: 2025-3-22 01:11 作者: 不公開 時間: 2025-3-22 05:01 作者: 嚴厲批評 時間: 2025-3-22 10:30
Chimerism in Hematopoietic Stem Cell Transplantationes in the successful engraftment of the donor stem cells in the host environment. The degree of donor cell component in the recovering hematopoiesis in the host is a critical factor which affects posttransplant immunomodulation, relapse of primary disease, posttransplant complications, and ultimatel作者: EXTOL 時間: 2025-3-22 15:08
HSCT in Malignanciesers or solid organ cancer. The better understanding of disease physiopathology and the continuous development of new therapeutic strategies has an incessant impact in HCT indication. In addition, the refinement in HCT techniques and supportive care has remarkable reduced transplant-related mortality作者: EXTOL 時間: 2025-3-22 19:44 作者: micronutrients 時間: 2025-3-23 00:12
Hemopoietic Stem Cell Transplant for Non-hematological Disordersrders is perhaps less obvious since the blood cells themselves function normally and there is no malignancy. The application of HCT in non-hematological disease is a growing area and is likely to concern all transplant physicians in the coming decades..HCT in leukemia is intuitive, even to the lay p作者: 紡織品 時間: 2025-3-23 02:50
Allogeneic Transplant Overview and Matched Related Donor Transplantignancies and other malignant and nonmalignant diseases. Since the first allogeneic transplants more than five decades ago, significant advances have occurred in transplantation technology, donor availability, and supportive care that have made transplantation safer and increasingly available to pat作者: 陳舊 時間: 2025-3-23 05:38
Haploidentical Transplantation: Challenges and Solutions hematological malignancies. The primary reason for this has been the emergence of posttransplantation cyclophosphamide as graft-versus-host disease (GVHD) prophylaxis, which by dint of both, its ease of application and impressive outcomes, has made HFD-HCT feasible across the globe. Studies have co作者: Bridle 時間: 2025-3-23 13:38 作者: 有機體 時間: 2025-3-23 14:20
Umbilical Cord Blood Transplantationtion. Umbilical cord blood, often discarded as a biological waste, is a potential means for cure of not only hematological disorders but also many non-hematological disorders like metabolic diseases, primary immunodeficiencies, and regenerative medicine. Though expanding donor registries for unrelat作者: 文件夾 時間: 2025-3-23 20:32 作者: 你不公正 時間: 2025-3-23 22:19 作者: 窒息 時間: 2025-3-24 05:30 作者: Lacunar-Stroke 時間: 2025-3-24 08:46
Graft Versus Host Disease: Management of Acute and Chronic Diseaseever, with all indications for allogeneic HCT, graft versus host disease (GVHD) has remained a common and often serious complication. Classical regimens aimed at prevention of GVHD, such as combinations of methotrexate or mycophenolate mofetil with a calcineurin inhibitor, with or without the additi作者: 吞吞吐吐 時間: 2025-3-24 14:22
Das Umwelthaftungsgesetz (UmweltHG)ate on the first years of sporadic worldwide procedures to the scientifically advanced cord and haploidentical transplants and the establishment of high quality donor registries and quality assurance of the transplant procedures worldwide.作者: Fallibility 時間: 2025-3-24 17:52 作者: padding 時間: 2025-3-24 23:02 作者: Paleontology 時間: 2025-3-25 02:37 作者: Fillet,Filet 時間: 2025-3-25 06:43
Versuchsergebnisse und Beurteilung, are associated with toxicities – early and late. A review of myeloablative, reduced intensity, and non-myeloablative conditioning, commonly used drugs and regimens in autologous and allogeneic transplant is provided. Factors influencing the choice of the conditioning intensity and choice of the conditioning regimens are discussed.作者: 名字 時間: 2025-3-25 08:35
History of Bone Marrow Transplantationate on the first years of sporadic worldwide procedures to the scientifically advanced cord and haploidentical transplants and the establishment of high quality donor registries and quality assurance of the transplant procedures worldwide.作者: 壯觀的游行 時間: 2025-3-25 11:54 作者: antenna 時間: 2025-3-25 16:00
Chimerism in Hematopoietic Stem Cell Transplantation overall donor component in posttransplant hematopoiesis but also the degree of donor chimerism in each hematopoietic cell lineage. This chapter is a review of biology of chimerism, methods for testing chimerism, and the clinical role of chimerism in guiding allogeneic stem cell transplantation management.作者: 名次后綴 時間: 2025-3-25 22:48
Unrelated Donor Allogeneic Transplantlso evolved. This chapter provides an overview of the current status of unrelated donor transplant with insights in to the role of HLA biology, donor selection criteria, management challenges, and outcomes with this strategy.作者: 中子 時間: 2025-3-26 04:02
Transplant Pharmacology and Conditioning Therapy are associated with toxicities – early and late. A review of myeloablative, reduced intensity, and non-myeloablative conditioning, commonly used drugs and regimens in autologous and allogeneic transplant is provided. Factors influencing the choice of the conditioning intensity and choice of the conditioning regimens are discussed.作者: 他去就結(jié)束 時間: 2025-3-26 06:40
2570-1592 are of transplant patients and illustrates practical challenBone Marrow transplantation or Hematopoietic stem cell transplantation is a life saving procedure in a number of diseases,hematological and non hematological, which fail alternative medical management or have no other treatment options. It 作者: 安撫 時間: 2025-3-26 10:28
Auswertung der Messungen in der Verteilung,splantation (HSCT). Better understanding of biological effects of ionizing radiation, improved dosimetry, and enhanced knowledge of radiation therapy-chemotherapy and/or biological interactions has led to refinement in the technique and the use of TBI. This chapter comprehensively addresses TBI in allogeneic stem cell transplantation.作者: conformity 時間: 2025-3-26 14:08 作者: Outspoken 時間: 2025-3-26 17:43 作者: 游行 時間: 2025-3-27 00:35 作者: 違法事實 時間: 2025-3-27 01:19
Reference work 2021logical, which fail alternative medical management or have no other treatment options. It has transformed the lives of thousands of patients and their families around the world battling with fatal or debilitating diseases.There are many unique aspects of bone marrow transplantation which makes it ve作者: Malaise 時間: 2025-3-27 08:35
https://doi.org/10.1007/978-3-663-07256-0and how aging impacts these important stem cells. It is also helpful to understand how the application of technology can improve the depth to which this complex stem and progenitor cell network is understood. This chapter will address these questions.作者: Lacunar-Stroke 時間: 2025-3-27 12:43
https://doi.org/10.1007/978-3-663-07361-1sorder with the risk of the transplant procedure and the results of nontransplant strategies. This chapter provides an overview of role of HCT in malignancies with a brief mention also of solid organ cancer transplantation.作者: 關(guān)節(jié)炎 時間: 2025-3-27 15:51 作者: 上下連貫 時間: 2025-3-27 18:00
Wilhelm Sturtzel,Werner Graff,Peter Jusczyk and manipulation of cord blood stem cells have renewed interest in this source. This chapter is a review of the evolution and current status of umbilical cord blood transplantation. Aspects covered include biology, indications, conditioning strategies, and complications of cord blood transplantation.作者: 障礙物 時間: 2025-3-27 23:58
Stem Cell Biology in Bone Marrow Transplantationand how aging impacts these important stem cells. It is also helpful to understand how the application of technology can improve the depth to which this complex stem and progenitor cell network is understood. This chapter will address these questions.作者: Atrium 時間: 2025-3-28 03:23
HSCT in Malignanciessorder with the risk of the transplant procedure and the results of nontransplant strategies. This chapter provides an overview of role of HCT in malignancies with a brief mention also of solid organ cancer transplantation.作者: intertwine 時間: 2025-3-28 06:43 作者: mydriatic 時間: 2025-3-28 13:36
Umbilical Cord Blood Transplantation and manipulation of cord blood stem cells have renewed interest in this source. This chapter is a review of the evolution and current status of umbilical cord blood transplantation. Aspects covered include biology, indications, conditioning strategies, and complications of cord blood transplantation.作者: fulcrum 時間: 2025-3-28 14:49 作者: etiquette 時間: 2025-3-28 22:14
,Interpretation der Me?ergebnisse,he HCT might attenuate illnesses and improve patients despite their being nothing wrong with the blood itself in the first place. The blood might be the best part of some of these patients, and yet to correct disease manifestations then all that is corrected is this blood..The use of HCT in inborn e作者: Macronutrients 時間: 2025-3-29 01:00
https://doi.org/10.1007/978-3-663-07364-2g each other out, depending on the conditioning, graft manipulation, and GVHD prophylaxis. Adoptive immunotherapy following haploidentical HCT is an exciting and expanding area in HCT, with the emergence of several approaches involving natural killer cells. The application of HFD-HCT in hemoglobinop作者: 嚙齒動物 時間: 2025-3-29 07:05
Versuchsergebnisse und Beurteilung,lapse is high. Currently, multiple myeloma, chemosensitive relapse Hodgkin’s lymphoma (HL), and diffuse large B-cell non-Hodgkin’s lymphoma (NHL) are important indications among adults and high-risk neuroblastoma in the pediatric age group. Current focus is to identify patients at higher risk of rel作者: fulmination 時間: 2025-3-29 07:42 作者: 積極詞匯 時間: 2025-3-29 15:09
Reference work 2021 cell transplants with latest insights about the technique and basic science.behind it . The book is the product of collective effort of transplant professionals round the world, and will reflect their experience as well as the current standard of care practices in Stem cell transplantation.The book作者: 憤怒事實 時間: 2025-3-29 19:16 作者: 賞錢 時間: 2025-3-29 19:46 作者: crucial 時間: 2025-3-30 03:45 作者: 破譯密碼 時間: 2025-3-30 06:56 作者: Biomarker 時間: 2025-3-30 10:03
Graft Versus Host Disease: Management of Acute and Chronic Diseasew modality. Further, manipulation of the intestinal microbiome has yielded interesting results in some studies. Glucocorticoids have so far remained the main stay of therapy of GVHD if it develops despite prophylaxis. The management of acute and in particular chronic GVHD requires a multidisciplinar作者: A精確的 時間: 2025-3-30 14:57 作者: DNR215 時間: 2025-3-30 19:47
https://doi.org/10.1007/978-3-030-36358-1Hematopoietic stem cells; stem cell transplant; Haploidentical stem cell transplantation; Immunosuppres作者: 一美元 時間: 2025-3-30 21:09
Springer Nature Switzerland AG 2021作者: Foregery 時間: 2025-3-31 01:51 作者: hereditary 時間: 2025-3-31 05:14 作者: nonsensical 時間: 2025-3-31 09:56 作者: instulate 時間: 2025-3-31 13:43 作者: 專心 時間: 2025-3-31 20:33
